Why it was recalled
Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.
Product description
Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL - bottle, Rx only, Manufactured by: Micro Labs Limited, India, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873. NDC 42571-147-26.
Lot numbers, UPCs & expiration codes
Lot # DLHU0031, Exp Date: 06/30/2027.
Where it was sold
Nationwide in the USA.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0730-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Jul 22, 2026
- FDA report date
- Aug 5, 2026
- Quantity
- N/A
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- MICRO LABS USA INC
Original FDA data
Every field from FDA enforcement report D-0730-2026, exactly as published.
Show all FDA fields
- City
- Somerset
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 99481
- Address
- 220 Davidson Ave
- Code information
- Lot # DLHU0031, Exp Date: 06/30/2027.
- Postal code
- 08873-4149
- Report date
- Aug 5, 2026
- Product type
- Drugs
- Recall number
- D-0730-2026
- Classification
- Class II
- Recalling firm
- MICRO LABS USA INC
- Reason for recall
- Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL - bottle, Rx only, Manufactured by: Micro Labs Limited, India, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873. NDC 42571-147-26.
- Distribution pattern
- Nationwide in the USA.
- Recall initiation date
- Jul 22, 2026
- Initial firm notification
- Letter
- Center classification date
- Jul 24, 2026